Jolien Ceusters

Validation of models to diagnose ovarian cancer in patients managed surgically or conservatively: multicentre cohort study

Ben Van Calster, L. Valentin, Wouter Froyman et al. · BMJ · 2020 · 125 citations · Full text

Medicine, Oncology, Surgery +17

Benign descriptors and <scp>ADNEX</scp> in two‐step strategy to estimate risk of malignancy in ovarian tumors: retrospective validation in <scp>IOTA5</scp> multicenter cohort

C. Landolfo, T. Bourne, Wouter Froyman et al. · Ultrasound in Obstetrics and Gynecology · 2022 · 58 citations · Full text

Medicine, Gynecology, Oncology +17

External Validation of the Ovarian-Adnexal Reporting and Data System (<scp>O-RADS)</scp> Lexicon and the International Ovarian Tumor Analysis 2-Step Strategy to Stratify Ovarian Tumors Into <scp>O-RADS</scp> Risk Groups

Stefan Timmerman, L. Valentin, Jolien Ceusters et al. · JAMA Oncology · 2022 · 48 citations · Full text

Medicine, Gynecology, Oncology +17

Opposite Macrophage Polarization in Different Subsets of Ovarian Cancer: Observation from a Pilot Study

Ann Vankerckhoven, Roxanne Wouters, Thomas Mathivet et al. · Cells · 2020 · 35 citations · Full text

Medicine, Immunology, Oncology +17

Myeloid-derived suppressor cells at diagnosis may discriminate between benign and malignant ovarian tumors

An Coosemans, Thaïs Baert, Jolien Ceusters et al. · International Journal of Gynecological Cancer · 2019 · 25 citations · Full text

Medicine, Immunology, Oncology +17